文献速递甲状腺与颈部外科围术期管理与 ERAS

原发性甲状旁腺功能亢进患者甲状旁腺切除术后肾结石复发的预测因素

What Predicts Recurrent Kidney Stone after Parathyroidectomy in Patients with Primary Hyperparathyroidism?
PubMed 文献 · J Am Coll Surg · 2020-04-21

本研究回顾性分析69例原发性甲状旁腺功能亢进(PHPT)合并肾结石病(KSD)并接受甲状旁腺切除术的患者,发现尽管术后血钙和PTH大多正常化,仍有54%患者持续高钙尿症,23%患者平均2.0±1.6年出现KSD复发;复发者年龄显著更轻(51±15 vs 60±13岁,p=0.02),年轻是复发的强预测因素。

要点

  • PHPT合并KSD患者甲状旁腺切除术后仍有23%复发KSD。
  • 术后54%患者持续高钙尿症,即使血钙正常。
  • 年轻患者术后KSD复发风险更高,需密切监测。

核心结论

  • 近四分之一的PHPT合并KSD患者在接受成功的甲状旁腺切除术后仍出现KSD复发,尽管血清钙已正常化。
  • 超过一半的患者术后持续存在高钙尿症。
  • 年轻患者是KSD复发的强预测因素,可能需要更密切的监测。

研究设计与样本

  • 单中心回顾性研究,纳入2008年1月至2018年7月期间就诊于泌尿外科门诊的KSD患者,诊断为合并PHPT并接受确定性甲状旁腺切除术,共69例。
  • 术前和术后检测血清钙、PTH、磷、25-OH维生素D及24小时尿液指标(体积、pH、钙、枸橼酸、草酸、尿酸、钠、肌酐)。
  • 通过常规诊断影像或症状性KSD确定结石复发。

主要发现

  • 甲状旁腺切除术时平均年龄为57±14岁。
  • 术前平均血清钙为10.6±0.5 mg/dL,24小时尿钙为378±209 mg/day,PTH为114±97 pg/mL。
  • 术后血清钙和PTH分别在69/69和62/69例患者中正常化。
  • 术后37/69例(54%)持续高钙尿症,16/69例(23%)出现KSD复发,平均复发时间为2.0±1.6年。

临床怎么用

  • 对于PHPT合并KSD接受甲状旁腺切除术的患者,术后应监测高钙尿症和KSD复发,尤其是年轻患者。
  • 尽管血清钙正常化,仍需警惕KSD复发,建议定期影像学随访。

局限性

  • 单中心回顾性研究,样本量有限(69例)。
  • 需要进一步研究以明确甲状旁腺切除术后KSD的病因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Some, but not all, patients with primary hyperparathyroidism (PHPT) and kidney stone disease (KSD) are cured of their nephrolithiasis after parathyroidectomy. The goal of this study was to identify risk factors for recurrent KSD despite successful parathyroidectomy in known stone formers with PHPT. STUDY DESIGN: We conducted a single-center retrospective review of patients presenting to urology clinic with KSD between January 2008 and July 2018, who were diagnosed with concurrent PHPT, and underwent definitive parathyroidectomy. Laboratory testing for serum calcium, PTH (parathyroid hormone), phosphorus and 25-OH-vitamin D, and 24-hour urine studies for volume, pH, calcium, citrate, oxalate, uric acid, sodium, and creatinine was performed pre- and post-parathyroidectomy. Stone recurrence was determined on routine diagnostic imaging or by symptomatic KSD. RESULTS: Mean age at parathyroidectomy was 57 ± 14 years. Pre-parathyroidectomy, mean serum calcium, 24-hour urine calcium, and PTH were 10.6 ± 0.5 mg/dL, 378 ± 209 mg/day, and 114 ± 97 pg/mL, respectively. Twenty-six of 69 patients (38%) had multigland parathyroid disease. After parathyroidectomy, serum calcium and PTH levels normalized in 69 of 69 and 62 of 69 patients, respectively. However, 37 of 69 patients (54%) had persistent hypercalciuria postoperatively, and 16 of 69 (23%) had recurrent KSD, on average, 2.0 ± 1.6 years after parathyroidectomy. Patients with recurrent KSD post-parathyroidectomy were significantly younger compared with patients without recurrent KSD (51 ± 15 vs 60 ± 13 years, p = 0.02). In a logistic regression model, younger age remains a strong predictive factor for recurrent KSD. CONCLUSIONS: Nearly one-quarter of PHPT patients with KSD who undergo successful parathyroidectomy present with recurrent KSD despite normalization of serum calcium, and more than half exhibit persistent calciuria. These patients were younger and may require closer monitoring for stone recurrence after successful parathyroidectomy. Further studies are needed to better identify the etiology of KSD post-parathyroidectomy.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Islam AK, Holt S, Reisch J, et al. What Predicts Recurrent Kidney Stone after Parathyroidectomy in Patients with Primary Hyperparathyroidism? J Am Coll Surg. 2020. PMID: 32330575. doi:10.1016/j.jamcollsurg.2020.04.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。